Recent Progress on Bile Acid Receptor Modulators for Treatment of Metabolic Diseases
Author:
Affiliation:
1. Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, DC 1910, Indianapolis, Indiana 46285, United States
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5b00342
Reference148 articles.
1. Beyond intestinal soap—bile acids in metabolic control
2. Bile acid receptors as targets for drug development
3. Targeting bile-acid signalling for metabolic diseases
4. Endogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR
5. Identification of a Nuclear Receptor for Bile Acids
Cited by 60 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cholapod and Cholaphanes for Recognition of Anions;Current Organic Chemistry;2023-11
2. Discovery, Structure–Activity Relationships, and In Vivo Activity of Dihydropyridone Agonists of the Bile Acid Receptor TGR5;Journal of Medicinal Chemistry;2023-08-28
3. Design and exploration of gut-restricted bifunctional molecule with TGR5 agonistic and DPP4 inhibitory effects for treating ulcerative colitis;European Journal of Medicinal Chemistry;2022-11
4. Design, Synthesis, and Biological Study of Novel Farnesoid X Receptor Agonist for the Treatment of Cholestatic Liver Disease;ChemistrySelect;2022-09-13
5. Structure‐Based Optimization of Novel Farnesoid X Receptor Agonist for the Treatment of Acetaminophen‐Induced Liver Injury;ChemistrySelect;2022-03-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3